Vir Biotechnology, Inc. VIR Total Cost of Revenue
Discontinued — last reported Q2 '25
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed August 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s total cost of revenue?
- Vir Biotechnology, Inc. (VIR) reported total cost of revenue of $11K in Q2 2025.
- How has Vir Biotechnology, Inc.'s total cost of revenue changed year-over-year?
- Vir Biotechnology, Inc.'s total cost of revenue decreased by 78.8% year-over-year, from $52K to $11K.
- What is the long-term trend for Vir Biotechnology, Inc.'s total cost of revenue?
- Over 3 years (2021 to 2024), Vir Biotechnology, Inc.'s total cost of revenue has grown at a -76.6% compound annual growth rate (CAGR), from $65.86M to $845K.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.